A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression

EZH2, a core component of PRC2 complex, silences global gene expression by tri-methylating histone H3K27. It remains an elusive question that EZH2 hyperexpression discords with its H3K27me3 activity of gene suppression in advanced prostate cancer. Here, we report a nascent RNA-dependent PHF19-YTHDC1 condensate capable of switching EZH2-mediated gene suppression to activation during prostate cancer progression. We found that the long isoform of PRC2 accessory subunit PHF19, PHF19L, was highly expressed in advanced prostate cancer that promoted the tumor progression and hormonal therapy resistance. Mechanistically, PHF19L was recruited to the m<sup>6</sup>A modified nascent RNA through YTHDC1 and formed a liquid-like YTHDC1-PHF19L condensate that pulled the EZH2 away from chromatin, resulting in reduced H3K27me3 deposition and the activated expression of EZH2-repressed genes. Therefore, our study reveals a biomolecular condensate that modulates the switch from EZH2-mediated epigenetic gene silence to activation during the progression of prostate cancer.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2025-10-23
DOI
https://doi.org/10.1073/pnas.2510386122
Citations
2
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression

Jia‐Peng He, Hong Weng, Xinghuan Wang, Mengmeng Guo et al.
2 citations
Proceedings of the National Academy of Sciences
RNA modifications and cancer
1.61
article

A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression

Jia‐Peng He, Hong Weng, Xinghuan Wang, Mengmeng Guo, Shi‐Di Tang, Hailiang Hu, Minghui Shi, Xian‐Tao Zeng, Dao‐Jing Ming, Jin‐Long Cui, Shuang-Ying Wang, Yi Cai, Shu Xi, Fei Li, Haozhe Zhang, Jinhui Zhang, Shaohua He, Shuai Yuan, Luyao Li, Danqi Wang, Meng-Yang Liu
article en
2 citations

Abstract

EZH2, a core component of PRC2 complex, silences global gene expression by tri-methylating histone H3K27. It remains an elusive question that EZH2 hyperexpression discords with its H3K27me3 activity of gene suppression in advanced prostate cancer. Here, we report a nascent RNA-dependent PHF19-YTHDC1 condensate capable of switching EZH2-mediated gene suppression to activation during prostate cancer progression. We found that the long isoform of PRC2 accessory subunit PHF19, PHF19L, was highly expressed in advanced prostate cancer that promoted the tumor progression and hormonal therapy resistance. Mechanistically, PHF19L was recruited to the m<sup>6</sup>A modified nascent RNA through YTHDC1 and formed a liquid-like YTHDC1-PHF19L condensate that pulled the EZH2 away from chromatin, resulting in reduced H3K27me3 deposition and the activated expression of EZH2-repressed genes. Therefore, our study reveals a biomolecular condensate that modulates the switch from EZH2-mediated epigenetic gene silence to activation during the progression of prostate cancer.

Proceedings of the National Academy of SciencesVol. 122(43)
Huaihua University (CN), Southern University of Science and Technology (CN), Wuhan University (CN), Zhongnan Hospital of Wuhan University (CN)
Openalex Percentile: Top 14%
RNA modifications and cancer
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.